Skip to main content
Top
Published in: BMC Public Health 1/2008

Open Access 01-12-2008 | Research article

"That is why I stopped the ART": Patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme

Authors: Mison Dahab, Salome Charalambous, Robin Hamilton, Katherine Fielding, Karina Kielmann, Gavin J Churchyard, Alison D Grant

Published in: BMC Public Health | Issue 1/2008

Login to get access

Abstract

Background

As ART programmes in African settings expand beyond the pilot stages, adherence to treatment may become an increasing challenge. This qualitative study examines potential barriers to, and facilitators of, adherence to ART in a workplace programme in South Africa.

Methods

We conducted key informant interviews with 12 participants: six ART patients, five health service providers (HSPs) and one human resources manager.

Results

The main reported barriers were denial of existence of HIV or of one's own positive status, use of traditional medicines, speaking a different language from the HSP, alcohol use, being away from home, perceived severity of side-effects, feeling better on treatment and long waiting times at the clinic. The key facilitators were social support, belief in the value of treatment, belief in the importance of one's own life to the survival of one's family, and the ability to fit ART into daily life schedules.

Conclusion

Given the reported uncertainty about the existence of HIV disease and the use of traditional medicines while on ART, despite a programme emphasising ART counselling, there is a need to find effective ways to support adherence to ART even if the individual does not accept biomedical concepts of HIV disease or decides to use traditional medicines. Additionally, providers should identify ways to minimize barriers in communication with patients with whom they have no common language. Finally, dissatisfaction with clinical services, due to long waiting times, should be addressed.
Literature
1.
go back to reference World Health Organization, UNAIDS, UNICEF: Towards universal access. Scaling up priority HIV/AIDS interventions in the health sectorProgress Report. 2007, WHO, World Health Organization, UNAIDS, UNICEF: Towards universal access. Scaling up priority HIV/AIDS interventions in the health sectorProgress Report. 2007, WHO,
2.
go back to reference Palella FJ, Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, SD H: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine. 1998, 338 (13): 853-860. 10.1056/NEJM199803263381301.CrossRefPubMed Palella FJ, Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, SD H: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine. 1998, 338 (13): 853-860. 10.1056/NEJM199803263381301.CrossRefPubMed
3.
go back to reference Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio MA, Knysz B, Dietrich M, Phillips AN, Lundgren JD: Decline in the AIDS and death rates in the EuroSIDA study: an observational study.Lancet. 2004, 362: 22-29. 10.1016/S0140-6736(03)13802-0.CrossRef Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio MA, Knysz B, Dietrich M, Phillips AN, Lundgren JD: Decline in the AIDS and death rates in the EuroSIDA study: an observational study.Lancet. 2004, 362: 22-29. 10.1016/S0140-6736(03)13802-0.CrossRef
4.
go back to reference Bangsberg DR: Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clinical Infectious Diseases. 2006, 43 (7): 939-941. 10.1086/507526.CrossRefPubMed Bangsberg DR: Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clinical Infectious Diseases. 2006, 43 (7): 939-941. 10.1086/507526.CrossRefPubMed
5.
go back to reference Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G: Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Annals of Internal Medicine. 2007, 146 (8): 564-573.CrossRefPubMed Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G: Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Annals of Internal Medicine. 2007, 146 (8): 564-573.CrossRefPubMed
6.
go back to reference Bangsberg DR, Acosta EP, Gupta R, Guzman D, Riley ED, Harrigan PR, Parkin N, Deeks SG: Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS. 2006, 20 (2): 223-231. 10.1097/01.aids.0000199825.34241.49.CrossRefPubMed Bangsberg DR, Acosta EP, Gupta R, Guzman D, Riley ED, Harrigan PR, Parkin N, Deeks SG: Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS. 2006, 20 (2): 223-231. 10.1097/01.aids.0000199825.34241.49.CrossRefPubMed
7.
go back to reference Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, Rachlis B, Wu P, Cooper C, Thabane L, Wilson K, Guyatt G, Bangsberg DR: Adherence to Antiretroviral Therapy in Sub-Saharan Africa and North America. A Meta-Analysis. JAMA. 2006, 296 (6): 679-690. 10.1001/jama.296.6.679.CrossRefPubMed Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, Rachlis B, Wu P, Cooper C, Thabane L, Wilson K, Guyatt G, Bangsberg DR: Adherence to Antiretroviral Therapy in Sub-Saharan Africa and North America. A Meta-Analysis. JAMA. 2006, 296 (6): 679-690. 10.1001/jama.296.6.679.CrossRefPubMed
8.
go back to reference Montessori V, Wood E, Beer SL: Virologic success rates drop off sharply with decreasing levels of adherence to antiretroviral therapy. 2000, Durban, South Africa Montessori V, Wood E, Beer SL: Virologic success rates drop off sharply with decreasing levels of adherence to antiretroviral therapy. 2000, Durban, South Africa
9.
go back to reference Palepu A, Yip B, Miller C, Strathdee SA, O'Shaughnessy MV, Montaner JS: Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use. AIDS. 2001, 15 (3): 423-424. 10.1097/00002030-200102160-00021.CrossRefPubMed Palepu A, Yip B, Miller C, Strathdee SA, O'Shaughnessy MV, Montaner JS: Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use. AIDS. 2001, 15 (3): 423-424. 10.1097/00002030-200102160-00021.CrossRefPubMed
10.
go back to reference Gifford A, Bormann J, Shively M, Wright B, Richman D, Bozzette S: Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndrome. 2000, 23: 386-395.CrossRef Gifford A, Bormann J, Shively M, Wright B, Richman D, Bozzette S: Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndrome. 2000, 23: 386-395.CrossRef
11.
go back to reference Haubrich RH, Little SJ, Currier JS, Forthal D, Cemper C, Beall G, Johnson D, Dube M, Hwang J, McCutchan A: The value of patient-reported adherence to antiretroviral therapy in predicting virologic and im- munologic response. AIDS. 1999, 13: 1099-1107. 10.1097/00002030-199906180-00014.CrossRefPubMed Haubrich RH, Little SJ, Currier JS, Forthal D, Cemper C, Beall G, Johnson D, Dube M, Hwang J, McCutchan A: The value of patient-reported adherence to antiretroviral therapy in predicting virologic and im- munologic response. AIDS. 1999, 13: 1099-1107. 10.1097/00002030-199906180-00014.CrossRefPubMed
12.
go back to reference Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, Wilson K, Buchan I, Gill CJ, Cooper C: Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLOS Medicine. 2006, 3 (11): e438-10.1371/journal.pmed.0030438.CrossRefPubMedPubMedCentral Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, Wilson K, Buchan I, Gill CJ, Cooper C: Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLOS Medicine. 2006, 3 (11): e438-10.1371/journal.pmed.0030438.CrossRefPubMedPubMedCentral
13.
go back to reference Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, Makhema J, Kebaabetswe P, Dickenson D, Mompati K, Essex M, Marlink R: Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. Journal of Acquired Immune Deficiency Sydrom. 2003, 34 (3): 281-288. 10.1097/00126334-200311010-00004.CrossRef Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, Makhema J, Kebaabetswe P, Dickenson D, Mompati K, Essex M, Marlink R: Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. Journal of Acquired Immune Deficiency Sydrom. 2003, 34 (3): 281-288. 10.1097/00126334-200311010-00004.CrossRef
14.
go back to reference Laniece I, Ciss M, Desclaux A, Diop K, Mbodj F, Ndiaye B, Sylla O, Delaporte E, Ndoye I: Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS. 2003, 17 Suppl 3: S103-8.CrossRefPubMed Laniece I, Ciss M, Desclaux A, Diop K, Mbodj F, Ndiaye B, Sylla O, Delaporte E, Ndoye I: Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS. 2003, 17 Suppl 3: S103-8.CrossRefPubMed
15.
go back to reference Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi PN, Bangsberg D: Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy. International Journal of STD & AIDS. 2005, 16: 38-41. 10.1258/0956462052932548.CrossRef Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi PN, Bangsberg D: Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy. International Journal of STD & AIDS. 2005, 16: 38-41. 10.1258/0956462052932548.CrossRef
16.
go back to reference Molassiotis A, Nahas-Lopez V, Chung WYR, Lam SWC, Li CKP, Lau TFJ: Factors associated with adherence to antiretroviral medication in HIV infected patients. International Journal of STD & AIDS. 2002, 13 (5): 301-310. 10.1258/0956462021925117.CrossRef Molassiotis A, Nahas-Lopez V, Chung WYR, Lam SWC, Li CKP, Lau TFJ: Factors associated with adherence to antiretroviral medication in HIV infected patients. International Journal of STD & AIDS. 2002, 13 (5): 301-310. 10.1258/0956462021925117.CrossRef
17.
go back to reference Pinheiro CA, de-Carvalho-Leite JC, Drachler ML, Silveira VL: Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: a cross-sectional study in Southern Brazil. Braz J Med Biol Res. 2002, 35 (10): 1173-1181. 10.1590/S0100-879X2002001000010.CrossRefPubMed Pinheiro CA, de-Carvalho-Leite JC, Drachler ML, Silveira VL: Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: a cross-sectional study in Southern Brazil. Braz J Med Biol Res. 2002, 35 (10): 1173-1181. 10.1590/S0100-879X2002001000010.CrossRefPubMed
18.
go back to reference Carvalho CV, Duarte DB, Merchan-Hamann E, Bicudo E, Laguardia J: Predictors of compliance with highly active antiretroviral therapy in Brasilia, Distrito Federal, Brazil, 1999-2000. Cad Saude Publica. 2003, 19 (2): 593-604.CrossRefPubMed Carvalho CV, Duarte DB, Merchan-Hamann E, Bicudo E, Laguardia J: Predictors of compliance with highly active antiretroviral therapy in Brasilia, Distrito Federal, Brazil, 1999-2000. Cad Saude Publica. 2003, 19 (2): 593-604.CrossRefPubMed
19.
go back to reference Monreal MT, da Cunha RV, Trinca LA: Compliance to antiretroviral medication as reported by AIDS patients assisted at the University Hospital of the Federal University of Mato Grosso do Sul. Brazilian Journal of Infectious Disease. 2002, 6 (1): 8-14.CrossRef Monreal MT, da Cunha RV, Trinca LA: Compliance to antiretroviral medication as reported by AIDS patients assisted at the University Hospital of the Federal University of Mato Grosso do Sul. Brazilian Journal of Infectious Disease. 2002, 6 (1): 8-14.CrossRef
20.
go back to reference Nachega J, Stein DM, Lehman DA, Hlatshwayo D, Mothopeng R, Chaisson RE, Karstaedt AS: Adherence to Antiretroviral Therapy in HIV-Infected Adults in Soweto, South Africa. AIDS Research and Human Retroviruses. 2004, 20 (10): 1053-1056. 10.1089/aid.2004.20.1053.CrossRefPubMed Nachega J, Stein DM, Lehman DA, Hlatshwayo D, Mothopeng R, Chaisson RE, Karstaedt AS: Adherence to Antiretroviral Therapy in HIV-Infected Adults in Soweto, South Africa. AIDS Research and Human Retroviruses. 2004, 20 (10): 1053-1056. 10.1089/aid.2004.20.1053.CrossRefPubMed
21.
go back to reference Nemes MI, de Carvalho CV, Souza MF: Antiretroviral therapy adherence in Brazil. AIDS. 2004, Supp 13 : S15-20. 10.1097/00002030-200406003-00004.CrossRef Nemes MI, de Carvalho CV, Souza MF: Antiretroviral therapy adherence in Brazil. AIDS. 2004, Supp 13 : S15-20. 10.1097/00002030-200406003-00004.CrossRef
22.
go back to reference Green J, Thorogood N: Qualitative Methods for Health Research. 2004, London , Sage publications, 262-1 Green J, Thorogood N: Qualitative Methods for Health Research. 2004, London , Sage publications, 262-1
23.
go back to reference Babb DA, Pemba L, Seatlanyane P, Charalambous S, Churchyard GJ, Grant AD: Use of traditional medicine by HIV-infected individuals in South Africa in the era of antiretroviral therapy. Psychology, Health & Medicine. 2007, 12 (3): 314-320. 10.1080/13548500600621511.CrossRef Babb DA, Pemba L, Seatlanyane P, Charalambous S, Churchyard GJ, Grant AD: Use of traditional medicine by HIV-infected individuals in South Africa in the era of antiretroviral therapy. Psychology, Health & Medicine. 2007, 12 (3): 314-320. 10.1080/13548500600621511.CrossRef
24.
go back to reference Dahab M, Hamilton R, Charalambous S, Dube N, Tsimele J, Govender N, Puso T, Dwadwa T, Kielmann K, Fielding K, Churchyard G, Grant A: A quantitative study of barriers & facilitators to adherence in an antiretroviral therapy programme in South Africa : Toronto, Canada.2006, , Dahab M, Hamilton R, Charalambous S, Dube N, Tsimele J, Govender N, Puso T, Dwadwa T, Kielmann K, Fielding K, Churchyard G, Grant A: A quantitative study of barriers & facilitators to adherence in an antiretroviral therapy programme in South Africa : Toronto, Canada.2006, ,
25.
go back to reference Reynolds NR: Adherence to antiretroviral therapies: state of the science. Current HIV Research. 2004, 2 (3): 207-214. 10.2174/1570162043351309.CrossRefPubMed Reynolds NR: Adherence to antiretroviral therapies: state of the science. Current HIV Research. 2004, 2 (3): 207-214. 10.2174/1570162043351309.CrossRefPubMed
26.
go back to reference Stone VE: Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice. Clinical Infectious Diseases. 2001, 33 (6): 865-872. 10.1086/322698.CrossRefPubMed Stone VE: Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice. Clinical Infectious Diseases. 2001, 33 (6): 865-872. 10.1086/322698.CrossRefPubMed
27.
go back to reference Ickovics JR, Meisler AW: Adherence in AIDS clinical trials: A framework for clinical research adn clinical care. Clinical Epidemiology. 1997, 50 (4): 385-391. 10.1016/S0895-4356(97)00041-3.CrossRef Ickovics JR, Meisler AW: Adherence in AIDS clinical trials: A framework for clinical research adn clinical care. Clinical Epidemiology. 1997, 50 (4): 385-391. 10.1016/S0895-4356(97)00041-3.CrossRef
28.
go back to reference Orrell C, Bangsberg D, Badri M, Wood R: Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS. 2003, 17 (9): 1369-1375. 10.1097/00002030-200306130-00011.CrossRefPubMed Orrell C, Bangsberg D, Badri M, Wood R: Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS. 2003, 17 (9): 1369-1375. 10.1097/00002030-200306130-00011.CrossRefPubMed
Metadata
Title
"That is why I stopped the ART": Patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme
Authors
Mison Dahab
Salome Charalambous
Robin Hamilton
Katherine Fielding
Karina Kielmann
Gavin J Churchyard
Alison D Grant
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2008
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-8-63

Other articles of this Issue 1/2008

BMC Public Health 1/2008 Go to the issue